Current staging of hepatocellular carcinoma: Imaging implications

Cancer Imaging

Volumn 6, Issue 1, 2006, Pages 83-94

  Bhosale, P ^a   Szklaruk, J ^a   Silverman, P M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hepatocellular carcinoma (HCC); Radiology and treatment; Staging

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33746419749     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2006.0014     Document Type: Article

References (22)

1. Clark HP, Carson WF, Kavanagh PV, Ho CP, Shen P, Zagoria RJ. Staging and current treatment of hepatocellular carcinoma. Radiographics 2005; 25 (Suppl. 1): S3-S23. (Pubitemid 41686059)
2. Merle P. Epidemiology, natural history and pathogenesis of hepatocellular carcinoma. Cancer Radiother 2005; 9: 452-7. (Pubitemid 41719059)
3. Lai EC, Lau WY. The continuing challenge of hepatic cancer in Asia. Surgeon 2005; 3: 210-15. (Pubitemid 40932721)
4. Oral contraceptives and liver cancer: results of the Multicentre International Liver Tumor Study (MILTS). Contraception 1997; 56: 275-84.
5. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005; 11: 1086-92. (Pubitemid 41341758)
6. Katyal S, Oliver JH 3rd, Peterson MS, Ferris JV, Carr BS, Baron RL. Extrahepatic metastases of hepatocellular carcinoma. Radiology 2000; 216: 698-703. (Pubitemid 30660840)
7. Kojiro M. Histopathology of liver cancers. Best Pract Res Clin Gastroenterol 2005; 19: 39-62. (Pubitemid 40331497)
8. Gorog D, Regoly-Merei J, Paku S, Kopper L, Nagy P. Alphafetoprotein expression is a potential prognostic marker in hepatocellular carcinoma. World J Gastroenterol 2005; 11: 5015-18. (Pubitemid 41227202)
9. Angelelli G, Ianora AA, Scardapane A, Pedote P, Memeo M, Rotondo A. Role of computerized tomography in the staging of gastrointestinal neoplasms. Semin Surg Oncol 2001; 20: 109-21. (Pubitemid 32520656)
10. Ichikawa T, Kitamura T, Nakajima H, Sou H, Tsukamoto T, Ikenaga S et al. Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? AJR Am J Roentgenol 2002; 179: 751-8. (Pubitemid 34919593)
11. Iannaccone R, Laghi A, Catalano C, Rossi P, Mangiapane F, Murakami T et al. Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 2005; 234: 460-7. (Pubitemid 40139917)
12. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J et al. Enhancement of focal liver lesions at gadoxetic acidenhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005; 234: 468-78. (Pubitemid 40139918)
13. Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S et al. Hepatic metastases: diffusionweighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006; 239: 122-30.
14. Merli M, Nicolini G, Gentili F, Novelli G, Iappelli M, Casciaro G et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 2005; 37: 2535-40. (Pubitemid 41354662)
15. Kim SJ, Seo HY, Choi JG, Sul HR, Sung HJ, Park KH et al. Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma. Cancer Chemother Pharmacol 2006; 57: 436-42. (Pubitemid 43087586)
16. Chan KM, Lee WC, Hung CF, Yu MC, Jan YY, Chen MF. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection. Chang Gung Med J 2005; 28: 543-50.
17. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005; 16: 779-90. (Pubitemid 40847898)
18. Lencioni R, Della Pina C, Bartolozzi C. Percutaneous imageguided radiofrequency ablation in the therapeutic management of hepatocellular carcinoma. Abdom Imaging 2005; 30: 401-8. (Pubitemid 41176117)
19. Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005; 43 (3): 458-64. (Pubitemid 41111427)
20. Xiao EH, Hu GD, Li JQ, Huang JF. Transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 2005; 27: 478-82.
21. Becker G, Soezgen T, Olschewski M, Laubenberger J, Blum HE, Allgaier HP. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma. World J Gastroenterol 2005; 11: 6104-9. (Pubitemid 43085049)
22. Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 2006; 16: 661-9. (Pubitemid 44149378)